logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lehui Inspection (01586.HK) spent HK$161,160 to repurchase 64,000 shares on May 15th.

date
15/05/2025
The Zhtng Finance and Economics app reported that Li Heng Testing (01586.HK) announced that on May 15, 2025, it spent 161,160 Hong Kong dollars to repurchase 64,000 shares.
Latest
3 m ago
Insiders said that the private equity firm Thomas Bravo has sold its remaining shares on the Nasdaq, making a profit of about $3.4 billion.
5 m ago
Royal Bank of Canada: Maintains Aardvark Therapeutics (AARD.US) rating from Outperform to Market Outperform, target price adjusted from $21.00 to $20.00.
5 m ago
U.S. stock market anomaly | Nasdaq China Golden Dragon Index falls more than 2%, Tiger Brokers (TIGR.US) falls more than 8%
8 m ago
The S&P 500 index rose by 0.3%, the Dow Jones index rose by 0.3%, and the Nasdaq index fell by 0.06%.
8 m ago
The S&P 500 index rose by 0.3%, the Dow Jones index rose by 0.3%, and the Nasdaq index fell by 0.06%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.